HCPCS C1602: Absorbable Antimicrobial-Eluting Bone Void Filler, Implantable
HCPCS Level II code C1602 identifies an implantable, absorbable bone void filler that elutes antimicrobial agents. This device is used in orthopedic procedures to fill bone defects while delivering local antimicrobial therapy, which can be clinically significant for reducing postoperative infection risk and supporting bone healing. Nationally, coding clarity for implantable combination products like this affects device billing, hospital charge capture, and payer coverage determinations.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical use and site-of-service implications, typical payer considerations, and what to expect in coverage and claims processing for this HCPCS Level II code. The publication summarizes benchmarks where available, outlines relevant policy and reimbursement themes, and provides clinical context for when an antimicrobial-eluting absorbable bone void filler is utilized. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for hcpcs C1602 policy alerts
Get alerted when payer policies referencing C1602 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code C1602 describes an implantable absorbable bone void filler that elutes antimicrobial agents. The item combines an orthopedic device and drug matrix designed to fill bone voids while providing local antimicrobial release to reduce infection risk.
Service Type: Implantable orthopedic bone void filler with antimicrobial elution
Typical Site of Service: Inpatient or outpatient surgical settings, including operating rooms and procedure suites where orthopedic implantable devices are placed